First phase I trial of single dose HSV 1716 in patients with primary or recurrent malignant glioma
Latest Information Update: 29 Aug 2013
At a glance
- Drugs HSV 1716 (Primary)
- Indications Glioma
- Focus Adverse reactions
- 29 Aug 2013 The study was extended further with an additional 12 patients treated according to the same protocol.
- 29 Aug 2013 New trial record